5-person biotech uses Santé health model to vet molecules' cardiac risks before paying for synthesis
alifcoder · x · 2026-11-16
The CSO of a 5-person biotech, facing a tight budget on its first synthesis order, tested AntLingAGI's Santé health model to check whether the molecules were worth producing. The model helps researchers understand cardiac risks, identify critical testing conditions, and interpret clinical measurements before money is spent on synthesis — potentially making early-stage drug research much smarter.
More from Apps
- Gemini subscriptions coming to Hermes agent app in Google-approved integration — Scobleizer · 2026-11-16
- Obsidian Starter Kit v6 ships free to owners, requires Obsidian 1.15.0+ with in-place migration — dSebastien · 2026-11-16
- Top 30 AI tools for researchers, organized across five research workflow stages — Faheem_uh · 2026-11-16
- Ahrefs Brand Radar adds by-intent chart splitting AI visibility across funnel stages — gaganghotra_ · 2026-11-16
- Founder benchmarks LLM vs Investormatch on the same pitch deck: generic VCs vs targeted matches — MartinGTobias · 2026-11-16
- User shares how his AI 'dot' resurfaced forgotten personal photos — yungcontent · 2026-11-16